株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

MediWound Ltd.:製品パイプライン分析

MediWound Ltd. - Product Pipeline Review - 2015

発行 Global Markets Direct 商品コード 321946
出版日 ページ情報 英文 22 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
MediWound Ltd.:製品パイプライン分析 MediWound Ltd. - Product Pipeline Review - 2015
出版日: 2015年09月09日 ページ情報: 英文 22 Pages
概要

MediWound Ltd.は、火傷および慢性的な傷の管理という、まだニーズの満たされていない領域における製品を開発・製造し、商品化する、バイオテクノロジー企業で、ニッチ市場に特化しています。同社の製品には、部分的に深い、あるいは全層的な熱傷による痕を取り除くのに使うものもあります。

当レポートでは、MediWound Ltd.における治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

MediWound Ltd.の基本情報

MediWound Ltd.の概要

  • 主要情報
  • 企業情報

MediWound Ltd.:R&Dの概要

  • 主な治療範囲

MediWound Ltd. :パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品

MediWound Ltd. :パイプライン製品の概況

  • 最終段階にあるパイプライン製品
    • 第III相にある製品/併用療法モダリティ
  • 治験段階にあるパイプライン製品
    • 第II相にある製品/併用療法モダリティ
  • 初期段階にあるパイプライン製品
    • 前臨床段階にある製品/併用療法モダリティ

MediWound Ltd. :薬剤プロファイル

  • bromelains
  • EscharEx
  • MWPC-003

MediWound Ltd. :パイプライン分析

  • 投与経路別
  • 分子タイプ別

MediWound Ltd. :最近のパイプライン動向

MediWound Ltd. :本社と子会社の所在地

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC07573CDB

Summary

Global Markets Direct's, 'MediWound Ltd. - Product Pipeline Review - 2015', provides an overview of the MediWound Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of MediWound Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of MediWound Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of MediWound Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the MediWound Ltd.'s pipeline products

Reasons to buy

  • Evaluate MediWound Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of MediWound Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the MediWound Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of MediWound Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of MediWound Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of MediWound Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • MediWound Ltd. Snapshot
    • MediWound Ltd. Overview
    • Key Information
    • Key Facts
  • MediWound Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • MediWound Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • MediWound Ltd. - Pipeline Products Glance
    • MediWound Ltd. - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • MediWound Ltd. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • MediWound Ltd. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • MediWound Ltd. - Drug Profiles
    • bromelains
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • EscharEx
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • MWPC-003
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • MediWound Ltd. - Pipeline Analysis
    • MediWound Ltd. - Pipeline Products by Route of Administration
    • MediWound Ltd. - Pipeline Products by Molecule Type
  • MediWound Ltd. - Recent Pipeline Updates
  • MediWound Ltd. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • MediWound Ltd., Key Information
  • MediWound Ltd., Key Facts
  • MediWound Ltd. - Pipeline by Indication, 2015
  • MediWound Ltd. - Pipeline by Stage of Development, 2015
  • MediWound Ltd. - Monotherapy Products in Pipeline, 2015
  • MediWound Ltd. - Phase III, 2015
  • MediWound Ltd. - Phase II, 2015
  • MediWound Ltd. - Preclinical, 2015
  • MediWound Ltd. - Pipeline by Route of Administration, 2015
  • MediWound Ltd. - Pipeline by Molecule Type, 2015
  • MediWound Ltd. - Recent Pipeline Updates, 2015

List of Figures

  • MediWound Ltd. - Pipeline by Top 10 Indication, 2015
  • MediWound Ltd. - Pipeline by Stage of Development, 2015
  • MediWound Ltd. - Monotherapy Products in Pipeline, 2015
  • MediWound Ltd. - Pipeline by Top 10 Route of Administration, 2015
  • MediWound Ltd. - Pipeline by Top 10 Molecule Type, 2015
Back to Top